ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Wansheng Wang
Matched on ORCID iD 0000-0002-2128-7501; OpenAlex author ID A5014198183. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2013: 3 papers · 2014: none · 2015: none · 2016: none · 2017: 1 paper
Papers 4
- A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. Co-author DOI 10.1038/bjc.2017.365↗
- Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics. Co-author DOI 10.1016/j.jprot.2013.03.031↗
- iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.jprot.2013.06.032↗
- Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Co-author DOI 10.1158/1940-6207.capr-12-0307↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaohui Liu · 3 shared papers, 2013–2017 · strength 0.16
- Paper A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. DOI 10.1038/bjc.2017.365↗
- Paper Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-bas… DOI 10.1016/j.jprot.2013.03.031↗
- Paper iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. DOI 10.1016/j.jprot.2013.06.032↗
- Pengyuan Yang · 3 shared papers, 2013–2017 · strength 0.16
- Paper A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. DOI 10.1038/bjc.2017.365↗
- Paper Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-bas… DOI 10.1016/j.jprot.2013.03.031↗
- Paper iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. DOI 10.1016/j.jprot.2013.06.032↗
- Dayong Jin · 3 shared papers, 2013 · strength 0.12
- Paper Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-bas… DOI 10.1016/j.jprot.2013.03.031↗
- Paper iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. DOI 10.1016/j.jprot.2013.06.032↗
- Paper Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. DOI 10.1158/1940-6207.capr-12-0307↗
- Wenhui Lou · 2 shared papers, 2013–2017 · strength 0.11
- Xiao-Lin Wang · 2 shared papers, 2013 · strength 0.08
- Paper Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-bas… DOI 10.1016/j.jprot.2013.03.031↗
- Paper iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. DOI 10.1016/j.jprot.2013.06.032↗
- Xiaolin Wang · 1 shared paper, 2017 · strength 0.07
- Yi Chen · 1 shared paper, 2013 · strength 0.04
- Xiaolin Wang · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.